Ameriprise’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-700,000
Closed -$39.7M 4132
2025
Q3
$39.7M Buy
+700,000
New +$35.9M 0.01% 1022
2025
Q1
Sell
-349,000
Closed -$8.44M 4081
2024
Q4
$8.44M Buy
+349,000
New +$8.65M ﹤0.01% 1930

Other funds holding HIMS

Ameriprise's HIMS Position: Q1 2026 in Review

Ameriprise reduced its Hims & Hers Health (HIMS) stake by 54% in Q1 2026, selling an estimated $7.25M and leaving 261,926 shares worth $5.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2377.

Ameriprise first reported a position in HIMS in Q4 2020 and has held it in 17 quarters since. The position peaked at $35.2M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Ameriprise held 261,926 shares of Hims & Hers Health worth $5.44M as of Q1 2026.
  • Ameriprise sold 306,831 Hims & Hers Health shares in Q1 2026, an estimated $7.25M.
  • Hims & Hers Health made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2377 holding.
  • Ameriprise first reported a position in Hims & Hers Health in Q4 2020 and has held it in 17 quarters since.
  • Ameriprise's Hims & Hers Health position peaked at $35.2M in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.